New biomedical engineering centre for Imperial
May 28, 2014Manufacturing and Production, Research and Development, Sales and Marketing Cambridge, imperial college london, johnson, medcity, uren
Imperial College London is to build a pioneering biomedical engineering centre that will cement London and the south east’s reputation …
Clinigen chief executive joins Ergomed board
May 28, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clinigen, ergomed, george
UK drug development
 services firm Ergomed has appointed Peter George to its
board as a non-executive director.

 George has over 20 …
Pfizer admits AstraZeneca defeat
May 27, 2014Manufacturing and Production, Research and Development, Sales and Marketing AZ, AstraZeneca, Pfizer, Read, buyout, merger
Pfizer has acknowledged that it will not make an offer for AstraZeneca following the firms’ failure to agree a price …
We can’t go on like this: patients must come first
May 27, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, bowel, denegri, flannagan, patients
When French pharmaceutical company Sanofi announced the appointment of Dr Anne Beal as chief patient officer in late March, the …
Wave of appointments for UK firm
May 27, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing hatch, wave
Amersham-based UK medical education company Wave has appointed three new members of staff. Charlotte Wilkinson joins as programme manager and …
Biogen gets CHMP thumbs up
May 27, 2014Sales and Marketing Biogen, CHMP, Gazyvaro (obinutuzumab), Nuwiq, Octapharma, Orphan, Roche, chronic lymphocytic leukaemia, plegridy
Biogen Idec is celebrating after the Committee for Medicinal Products for Human Use (CHMP) gave its multiple sclerosis drug Plegridy …
Sales forecasts leave Sovaldi top and Januvia lagging
May 23, 2014Sales and Marketing Gilead, Januvia, Merck, diabetes, ep, hep C, sovaldi
Sovaldi has topped analysts’ estimates for future growth but Merck’s big-selling diabetes drug Januvia is falling by the wayside. This …
Janssen abandons Simponi application
May 23, 2014Sales and Marketing Europe, Janssen, RA, Simponi, rheumatoid arthritis
Janssen Biologics has withdrawn its application to add an intravenous (IV) form to the marketing authorisation of veteran rheumatoid arthritis …
Merck Serono rapped over hospitality
May 23, 2014Medical Communications, Sales and Marketing ABPI, Merck KGaA, Merck Serono, PMCPA
The use of ‘extravagant’ dinners and ‘excessive alcohol’ has landed Merck Serono in hot water with the PMCPA as it’s …
PAN appoints two and promotes three
May 23, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pan, doshi, fleming, gibbs, regan, valentine
Creative agency PAN has reinforced its account handling and planning teams with two new arrivals and three promotions. Aisha Regan …
Authorities visit Roche China offices
May 23, 2014Manufacturing and Production, Medical Communications, Sales and Marketing China, GSK, Roche, Witty, hangzhou, saic
A unit of China’s antitrust regulator has visited Roche’s offices in Hangzhou, according to media reports. The pharma industry has …
Novartis pays $200m for eye technology
May 22, 2014Sales and Marketing Novartis, eye technology, fovista, ophthotech, wet and
Novartis has bought the rights to licence and commercialise a novel anti-PGDF therapy which it is currently trialling in Phase …
PM Society announces new co-chairs
May 22, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PRIME, farrow, jones, o'brien, pm society
The PM Society is set to expand its reach across pharma and service firms through the new appointments of co-chairs …
ABPI hires new head of Commercial
May 22, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Watson
The ABPI has appointed David Watson as its new head of Commercial, who will be reporting to the association’s Commercial …
‘Stop Alzheimer’s testing on animals’
May 22, 2014Research and Development, Sales and Marketing AZ, Alzheimer's, Pfizer, humane, langley
Animals should not be used for Alzheimer’s research according to a new paper, because scientists should instead be looking at …
BMS and AbbVie get FDA lift
May 21, 2014Research and Development, Sales and Marketing AbbVie, BMS, FDA, elotuzumab, multiple, myeloma
Bristol-Myers Squibb and AbbVie are celebrating after receiving breakthrough designation status from the US regulator for their investigational medicine elotuzumab …
Gilead price lambasted by US health insurers
May 21, 2014Medical Communications, Sales and Marketing Gilead, Incivek, Victrelis, hepatitis C, sovaldi
Gilead’s new hepatitis C pill Sovaldi is coming under more pressure in the US as health insurers hit out at …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
